Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex

NCT01730209 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT01730209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01730209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex
Lead sponsor
Erasmus Medical Center
Phase
Phase 2/3
Overall status
Unknown status
Start date
November 30, 2012
Completion date
November 30, 2016
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tsc related autism, tsc related cognitive disability, tsc related learning problems, tuberous sclerosis complex